Publication: HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study
dc.contributor.author | Somnuek Sungkanuparph | en_US |
dc.contributor.author | Rebecca Oyomopito | en_US |
dc.contributor.author | Sunee Sirivichayakul | en_US |
dc.contributor.author | Thira Sirisanthana | en_US |
dc.contributor.author | Patrick C.K. Li | en_US |
dc.contributor.author | Pacharee Kantipong | en_US |
dc.contributor.author | Christopher K.C. Lee | en_US |
dc.contributor.author | Adeeba Kamarulzaman | en_US |
dc.contributor.author | Liesl Messerschmidt | en_US |
dc.contributor.author | Matthew G. Law | en_US |
dc.contributor.author | Praphan Phanuphak | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Chulalongkorn University | en_US |
dc.contributor.other | Foundation for AIDS Research | en_US |
dc.contributor.other | Research Institute for Health Sciences | en_US |
dc.contributor.other | Chiang Rai Regional Hospital | en_US |
dc.contributor.other | Kirby Institute | en_US |
dc.contributor.other | Queen Elizabeth Hospital Hong Kong | en_US |
dc.contributor.other | Hospital Sungai Buloh | en_US |
dc.contributor.other | University of Malaya | en_US |
dc.contributor.other | Faculty of Medicine, Ramathibodi Hospital, Mahidol University | en_US |
dc.date.accessioned | 2018-05-03T08:32:57Z | |
dc.date.available | 2018-05-03T08:32:57Z | |
dc.date.issued | 2011-04-15 | en_US |
dc.description.abstract | (See editorial commentary by Jordan on pages 1058-1060.)Of 682 antiretroviral-naïve patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with ≥1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia. © 2011 The Author. | en_US |
dc.identifier.citation | Clinical Infectious Diseases. Vol.52, No.8 (2011), 1053-1057 | en_US |
dc.identifier.doi | 10.1093/cid/cir107 | en_US |
dc.identifier.issn | 15376591 | en_US |
dc.identifier.issn | 10584838 | en_US |
dc.identifier.other | 2-s2.0-79953837870 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/12541 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953837870&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953837870&origin=inward | en_US |